DONNA BOWERS & ALAN MILLER

Size: px
Start display at page:

Download "DONNA BOWERS & ALAN MILLER"

Transcription

1 BAYLOR HEALTH CARE SYSTEM ONCOLOGY NETWORK NEWS UPDATE WITH YOUR BHCS ONCOLOGY ANCHORS DONNA BOWERS & ALAN MILLER 1

2 The Evolution of Cancer Care Slash, burn and poison era Precision Medicine Casting out evil spirits Modern Chemo- Radiotherapy Minimally Invasivesurgery 2

3 To Provide the Best Possible Chance for Patients We are practicing Precision Medicine and not just talking about it. With each individual we work as hard as possible to find an Achille s heel (target) in a patient s tumor and not just use the next new agent to come along. We are mobilizing all the tools at our disposal to maximize the chances of providing benefit with the next therapy. 3

4 Breast Cancer Currently all Breast Cancer patients assessed for: ER &PR status, HER2 Expression, EGFR BRCAI and BRCAII expression with appropriate history Currently there are 10 open clinical trials using biomarker data as treatment criteria, & a study collecting biomarker data in triple negative breast cancer. A national study complete genome sequencing of patients with triple negative breast cancer is being led by Baylor s Dr. Joyce O Shaughnessy. The first patient (a Baylor patient) to be sequenced was found to have three unique targets for precision therapy. 14 patients have now been sequenced data being analyzed 4

5 TRIPLE NEGATIVE BREAST CANCER PATIENT Sequenced and Found Lesions in both PI3K/AKT/mTOR and Ras/MEK/ERK PATIENT TREATED WITH DUAL-TARGETING STRATEGY BASED ON SEQUENCING INFORMATION Before 3/7/11 Post 2 cycles 5/4/11 Patnaik et al. ASCO June 2011 # 2502

6 medfusion Delivering the Tools 6

7 Precise and Personal 7

8 The patient and her doctor tell the story. 8

9 Dan Von Hoff says, And You Have So Many Great Docs I believe in many instances you have the best clinical investigator talent in the U.S. But not many people know DVH

10 Clinical Trial Accruals by Tumor Type CY 2009 Total Patient Accrual CY 2010 Total Patient Accrual CY 2011 Total Patient Accrual CY 2009 CY 2010 CY

11 Clinical Trials Accruals by Facility It is our goal to make cancer clinical research available throughout the January - August 2011 Baylor & Texas Oncology Intervention Accruals by Facility 333 BHCS. Trials currently available at All Saints, BUMC, Garland, Grapevine and Plano. 250 Infrastructure and trials being added at Irving. 200 The Innovative Clinical Trials Center is being developed at Fort Worth Garland Grapevine Plano Sammons BUMC, to bring new therapies at the earliest possible opportunity to our patients. Through BRI new researchers are joining the team, and translational research discoveries being made available to our patients. 11

12 Source: CY 2009 THCIC Data

13 Source: CY 2009 THCIC Data

14 Source: CY 2009 THCIC Data

15 Oncology Presence Map of North Texas with BHCS locations. Map of State with BHCS and Texas Oncology locations. 15

16 Nationally Ranked-By Volumes BUMC is 17th out of 100 Hospitals for Inpatient Oncology Volumes More Volume Than: City of Hope Moffitt Cancer Center Roswell Park Cancer Institute Johns Hopkins Northwestern Memorial Hospital Vanderbilt University Medical Center Yale-New Haven Hospital + many others Closing In On: Dana Farber Cancer Institute Mass General Hospital Duke University Medical Center Cedars-Sinai Medical Center Volume Leaders: MD Anderson Memorial Sloan Kettering Mayo Clinic Barnes-Jewish NY-Presbyterian/Columbia and Cornell Medicare Only US News & World Report 16

17 BHCS Oncology Vision Our vision is for the Baylor Health Care System to be recognized as a worldrenowned destination for cancer-related services. 17

18 BHCS Oncology Strategy Existing Vital Components: Patient Volumes Cohesive Network Organizational Leadership/Structure Strong physician partnerships Organizational Commitment Community and philanthropic support Passion to succeed by all Strategies: BHCS Oncology Strategic Plan Entity Specific Oncology Strategic Plans Performance Dashboards Structured update and working meetings with various leaders across the system Naming Initiative Moving the Charles A. Sammons Cancer Center name across the system 18

19 Developing BHCS Oncology Councils NURSING PHYSICIAN ADMINISTRATIVE 19

20 What Does a BHCS Oncology Network Mean? 20

Hope. has a new home. Baylor Charles A. Sammons Cancer Center at Dallas

Hope. has a new home. Baylor Charles A. Sammons Cancer Center at Dallas Hope has a new home Baylor Charles A. Sammons Cancer Center at Dallas Perkins + Will This is a special paid-advertising supplement. The content was not prepared or reviewed by the news staff of the business

More information

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader: SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental

More information

Kinds of Case Statements

Kinds of Case Statements Kinds of Case Statements CASE-A-PALOOZA Grace Hong, formerly of Duke Ellington School of the Arts Katharina Steinkellner, SOS Children s Villages International Kathy Swayze, Impact Communications 1. A

More information

Finding the Positives in Triple-Negative Breast Cancer:

Finding the Positives in Triple-Negative Breast Cancer: Finding the Positives in Triple-Negative Breast Cancer: A Three-Part Live CME Webcast Series Seminar I Wednesday, March 3, 2010 Faculty Clifford Hudis, MD Lisa A Carey, MD Seminar II Thursday, March 11,

More information

CYPRESS U CRITICAL UPDATE

CYPRESS U CRITICAL UPDATE CYPRESS U CRITICAL UPDATE CASE STUDIES IN CANCER CARE MANAGEMENT John Van Dyke, Interlink Copyright INTERLINK Care Management, Inc. 2014 Presented by: John Van Dyke Chief Executive Officer INTERLINK COE

More information

Study of Triple-Negative Breast Cancer is Most Cited in AACR Journal

Study of Triple-Negative Breast Cancer is Most Cited in AACR Journal MEDIA CONTACT: Craig Civale Craig.Civale@BaylorHealth.edu (817)709-7067 Study of Triple-Negative Breast Cancer is Most Cited in AACR Journal TGen, Baylor, US Oncology study revealed therapeutic drug targets

More information

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL We represent 23 of our nation s leading cancer hospitals on the National Comprehensive Cancer Network

More information

Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology. July 20-21, Washington DC

Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology. July 20-21, Washington DC Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology July 20-21, Washington DC OVERVIEW Ya-Chen Tina Shih, PhD Professor and Section Chief Section of Cancer Economics

More information

/ NCCN. ACS (www.cancer.org) NCC (www.nccn.org) NCCN NCCN ACS ACS-2345

/ NCCN. ACS (www.cancer.org) NCC (www.nccn.org) NCCN NCCN ACS ACS-2345 /2002 9 /2002 9 (NCCN) (ACS) NCCN ACS (www.cancer.org) NCC (www.nccn.org) NCCN 1-888-909-NCCN ACS 1-800-ACS-2345 NCCN ACS NCCN NCCN ACS NCCN 2002 (NCCN) (ACS) NCCN ACS ...................................

More information

DiaTech Oncology, LLC Developer of CorrectChemo Assay

DiaTech Oncology, LLC Developer of CorrectChemo Assay Emerging Value of the CorrectChemo Apoptosis Assay in Oncology Care Cary A. Presant, M.D., F.A.C.P. Chief Medical Officer, DiaTech Oncology Staff Physician, City of Hope Professor of Clinical Medicine,

More information

London Regional Cancer Program

London Regional Cancer Program London Regional Cancer Program Table of Contents Mission, Vision and Values...1 Key Areas and Directions... 2 Leading in Patient Care and Service Delivery... 2 Improving Quality and Safety... 5 Strengthening

More information

METASTATIC BREAST CANCER

METASTATIC BREAST CANCER Click Here to View at: www.iqanda-mbc.com The iq&a interactive Medical Intelligence Zone for METASTATIC BREAST CANCER Focus on Evidence-Based Treatment for Survival Prolongation Based on Receptor Status,

More information

Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer

Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Questions Answered by Andrea Apolo, MD is a Lasker Clinical Research Scholar and tenure-track

More information

Opportunity and Challenge

Opportunity and Challenge Opportunity and Challenge Implementation of Comparative Effectiveness Research: The Patient Protection and Affordable Care Act Dr. Ellen V. Sigal, Chair & Founder, Friends of Cancer Research Comparative

More information

Strategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer

Strategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer 2016-2018 Strategic Direction At The Kids Cancer Project our vision is to find a cure for kids cancer Our commitment Through the power of science, The Kids Cancer Project is at the forefront fighting for

More information

Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study

Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study SLA Annual Conference Biomedical & Life Sciences Division Breakfast June 2017 Amy Braden,

More information

San Antonio Breast Cancer Symposium December 5-9, 2017

San Antonio Breast Cancer Symposium December 5-9, 2017 Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, as 3rd-line Therapeutic Option for Patients With Relapsed/Refractory Metastatic Triple-Negative Breast Cancer (mtnbc): Efficacy

More information

Research goal is to identify better diagnostic, vaccine and treatment targets for chlamydia and gonorrhea

Research goal is to identify better diagnostic, vaccine and treatment targets for chlamydia and gonorrhea FOR IMMEDIATE RELEASE Contact: Chris Hardwick SOM Office of Public Affairs 410-706-5260 UNIVERSITY OF MARYLAND SCHOOLS OF DENTISTRY AND MEDICINE RECEIVE $10.7M GRANT TO CONDUCT SYSTEMS BIOLOGY RESEARCH

More information

An Extraordinary Resource for Cancer Care

An Extraordinary Resource for Cancer Care An Extraordinary Resource for Cancer Care Anderson Family Cancer Institute The Campaign for Jupiter Medical Center Gaining Critical Mass Against Cancer $50 Million fundraising goal to build our new cancer

More information

Support. Connect. Inspire. CNIB s Peer Support and Mentorship Programs

Support. Connect. Inspire. CNIB s Peer Support and Mentorship Programs Support. Connect. Inspire. CNIB s Peer Support and Mentorship Programs This page has been intentionally left blank Sight Loss: A Growing Issue In Ontario today, more than two million people are living

More information

CancerUpdateDFW. From Cancer to Health TM. A Biobehavioral Intervention for Cancer Patients. In this Issue. Winter Volume

CancerUpdateDFW. From Cancer to Health TM. A Biobehavioral Intervention for Cancer Patients. In this Issue. Winter Volume CancerUpdateDFW From Cancer to Health TM A Biobehavioral Intervention for Cancer Patients Treating cancer takes more than medical intervention. Science has confirmed the importance of psychological, behavioral,

More information

Strategy Registered Charity

Strategy Registered Charity Strategy 2015-2025 Registered Charity 516898 Why do we exist? Yorkshire has the third worst cancer incidence rates in England. 11 of 13 local authorities in the county have outcomes below the national

More information

REPORT. A Model Clinical Trials System for the 21st Century

REPORT. A Model Clinical Trials System for the 21st Century www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System

More information

Baylor Health's Strategy for Advancing Healthcare and Leveraging the Value of Laboratory Testing

Baylor Health's Strategy for Advancing Healthcare and Leveraging the Value of Laboratory Testing Baylor Health's Strategy for Advancing Healthcare and Leveraging the Value of Laboratory Testing Executive War College Discussion document April 30, 2013 Disclosures of conflict of interests Fully employed

More information

PACGENE. A Research Project funded by the National Cancer Institute. Not for Patient Use (R01 CA 97075)

PACGENE. A Research Project funded by the National Cancer Institute. Not for Patient Use (R01 CA 97075) Not for Patient Use PACGENE A Research Project funded by the National Cancer Institute (R01 CA 97075) Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE Consortium) Tackling an important problem.

More information

Strategic Plan

Strategic Plan YMCA of Whittlesea Healthier, happier, connected communities Strategic Plan 2013-2018 For more than 25 years, the YMCA of Whittlesea has been dedicated to strengthening people and the community. Today

More information

PATIENT S GUIDE. Transforming Cancer Care with Proton Therapy. Is Proton Therapy Right for You?

PATIENT S GUIDE. Transforming Cancer Care with Proton Therapy. Is Proton Therapy Right for You? PATIENT S GUIDE Transforming Cancer Care with Proton Therapy. Is Proton Therapy Right for You? Whatever time I have left to live is there because of proton therapy. And I am eternally grateful and I thank

More information

Spring 2018 Symposium Chairs 10 th Anniversary Event April 3-5, Maui. Precision Oncology Knowledge Networks CI4CC

Spring 2018 Symposium Chairs 10 th Anniversary Event April 3-5, Maui. Precision Oncology Knowledge Networks CI4CC Spring 2018 Symposium Chairs 10 th Anniversary Event April 3-5, Maui Precision Oncology Knowledge Networks Warren Kibbe, PhD CI4CC Sorena Nadaf, MS, MMI Ci4CC Past Conferences Dates Location Chairs Theme

More information

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential

More information

Surgery saved my life. Rehab is restoring my future.

Surgery saved my life. Rehab is restoring my future. The Best Way Back Baylor Institute for Rehabilitation offers care for the most challenging and medically complex patients, including those with traumatic brain injury, traumatic spinal cord injury and

More information

The Integration of Palliative Care into Standard Oncology Care. American Society of Clinical Oncology Provisional Clinical Opinion

The Integration of Palliative Care into Standard Oncology Care. American Society of Clinical Oncology Provisional Clinical Opinion The Integration of Palliative Care into Standard Oncology Care American Society of Clinical Oncology Provisional Clinical Opinion The Provisional Clinical Opinion Based on strong evidence from a phase

More information

Connecting the Dots Social Media and Influence. Nancy Benavente Cedars Sinai Medical Center

Connecting the Dots Social Media and Influence. Nancy Benavente Cedars Sinai Medical Center Connecting the Dots Social Media and Influence Nancy Benavente Cedars Sinai Medical Center Nabenavente@gmail.com CARA 2011 1 Everything you do should at least create the beginning of a relationship 2 Relationships

More information

In Cancer s Genes. Pauline Helle, Co-President of Think Pink McGill

In Cancer s Genes. Pauline Helle, Co-President of Think Pink McGill In Cancer s Genes Pauline Helle, Co-President of Think Pink McGill Recent and even controversial findings give an astonishing glimpse into the future of research, prevention and potential cure for breast

More information

Understanding Molecular Mechanisms of Cancers

Understanding Molecular Mechanisms of Cancers Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/understanding-molecular-mechanisms-ofcancers/3720/

More information

VA Recovery Transformation & Local Recovery Coordinators

VA Recovery Transformation & Local Recovery Coordinators VA Recovery Transformation & Local Recovery Coordinators David Carroll, Ph.D. Director, Recovery Services Office of Mental Health Services Department of Veterans Affairs David.Carroll@va.gov April 27,

More information

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential

More information

YMCA of Niagara Strategic Plan ymcaofniagara.org

YMCA of Niagara Strategic Plan ymcaofniagara.org YMCA of Niagara Strategic Plan 2016-2019 ymcaofniagara.org Table of Contents Our YMCA Today... 3 The Time Is Now... 4 The Canada We Want... 5 The Road Ahead... 5 The YMCA We Need... 5 Our Commitment...

More information

How to Integrate Peer Support & Navigation into Care Delivery

How to Integrate Peer Support & Navigation into Care Delivery How to Integrate Peer Support & Navigation into Care Delivery Andrew Bertagnolli, PhD Care Management Institute Why Integrate Peer Support into the Care Delivery Pathway? Improved health Increased feelings

More information

Society s happiness is a social responsibility

Society s happiness is a social responsibility 28 Society s happiness is a social responsibility Dr. Emad Saad Chairman Consultant for social responsibility And sustainability for companies Email: emadsaad126@gmail.com In occasion of the International

More information

OHSU Knight Cancer Institute Overview and Update

OHSU Knight Cancer Institute Overview and Update OHSU Knight Cancer Institute Overview and Update for Senate Health Care and Human Services Committee Steve Stadum, COO, OHSU Knight Cancer Institute September 15, 2014 Presentation Brief Overview of OHSU

More information

Child Neurology Foundation

Child Neurology Foundation Child Neurology Foundation Creating a Community of Support 2017-2021 Strategic Plan Page 1 Our Mission How We ll Get There To serve as a collaborative center of education and support for children and families

More information

It s an exciting time for pharmaceutical companies in the. Oncology Reps New Mantra: Provide Real Value, Maintain Physician Access

It s an exciting time for pharmaceutical companies in the. Oncology Reps New Mantra: Provide Real Value, Maintain Physician Access SALES & MARKETING INSIGHTS Oncology Reps New Mantra: Provide Real Value, Maintain Physician Access By Ganesh Vedarajan and Jon Roffman, It s an exciting time for pharmaceutical companies in the oncology

More information

CANCER DRUG DEVELOPMENT

CANCER DRUG DEVELOPMENT FACILITATING SUCCESSFUL CANCER DRUG DEVELOPMENT TURNING TRIALS INTO THERAPY TRIAL ACCELERATION SERVICES: Physician-Focused Patient Recruitment TRANSLATING INNOVATION INTO PATIENT CARE CLINICAL APPLICATION

More information

ONTARIO CANCER PLAN

ONTARIO CANCER PLAN ONTARIO CANCER PLAN 2011-2015 I want to live... I m still young, many people in my family have lived to be 100. I want to be around to watch my grandchildren grow up. Screening saved my life, I tell everybody

More information

Diversity Clinical Research Workshop Invited Faculty

Diversity Clinical Research Workshop Invited Faculty Diversity Clinical Research Workshop Invited Faculty Alex A. Adjei, MD, PhD, FACP Professor and Chair, Department of Medicine Senior Vice President of Clinical Research The Katherine Anne Gioia Chair in

More information

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina FIRST ANNOUNCEMENT 8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina The 8 th Conference of IAOC "Current

More information

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility Patient and Public Involvement, Engagement and Participation Strategy 2017-2022 NIHR Newcastle Clinical Research Facility Context The NIHR Newcastle Clinical Research Facility (CRF) delivers high quality,

More information

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN 2016-2021 VISION Leading the improvement of musculoskeletal health for patients across their lifespan through research and education. MISSION To enhance the

More information

Vision 2025: Summary

Vision 2025: Summary Vision 2025: Summary At the Royal Berkshire NHS Foundation Trust our vision is: Working together to provide outstanding care for our community We have a rich history of providing healthcare to the people

More information

From the director. Joe V. Selby, MD, MPH

From the director. Joe V. Selby, MD, MPH For 50 years, the Division of Research has been a central component in Kaiser Permanente s commitment to be a learning organization, dedicated to understanding and improving the health of Kaiser Permanente

More information

Science Report ADVANCES IN CANCER RESEARCH

Science Report ADVANCES IN CANCER RESEARCH Science Report ADVANCES IN CANCER RESEARCH Created by Huntsman Cancer Institute s Office of Communications 2016 www.huntsmancancer.org OUR TIME BEGAN with an empty lot and a dream full of promise, determination,

More information

New Drug development and Personalized Therapy in The Era of Molecular Medicine

New Drug development and Personalized Therapy in The Era of Molecular Medicine New Drug development and Personalized Therapy in The Era of Molecular Medicine Ramesh K. Ramanathan MD Virginia G. Piper Cancer Center Translational Genomics Research Institute Scottsdale, AZ Clinical

More information

Cancer Research in the EU Framework Programmes for RTD

Cancer Research in the EU Framework Programmes for RTD Cancer Research in the EU Framework Programmes for RTD Action against cancer: European platform Maria Vidal, MD, PhD Deputy Head of Unit Medical and public health research Health Directorate DG Research

More information

A t the retiring of a distinguished oncology career and after working with thousands of

A t the retiring of a distinguished oncology career and after working with thousands of HISTORY A t the retiring of a distinguished oncology career and after working with thousands of oncology patients, Gary T. Kimmel, M.D., recognized a need for further intervention with his patients before,

More information

September MESSAGING GUIDE 547E-EN (317)

September MESSAGING GUIDE 547E-EN (317) September 2016 1 MESSAGING GUIDE 547E-EN (317) Contents OVERVIEW 3 4 ABOUT THIS GUIDE BRINGING ROTARY S BRAND STORY TO LIFE WHAT WE SAY & HOW WE SOUND 5 5 WHAT IS MESSAGING? ROTARY S BRAND VOICE TAILORING

More information

Personalising medicine and mainstreaming genomics: the impact on nursing

Personalising medicine and mainstreaming genomics: the impact on nursing Personalising medicine and mainstreaming genomics: the impact on nursing Wednesday 10 th May 2017 Louise Banks, Jenny Hiley Hilary Fanning, Emma Skinner & Charlotte Hitchcock West Midlands Genomic Medicine

More information

Ruth McCorkle, PhD; Rebecca Kirch, JD; Kim Thiboldeaux; Julie Taylor; and Mark Gorman

Ruth McCorkle, PhD; Rebecca Kirch, JD; Kim Thiboldeaux; Julie Taylor; and Mark Gorman 947 Journal of the National Comprehensive Cancer Network The Alliance for Quality Psychosocial Cancer Care: An Innovative Model for Disseminating and Improving Implementation of National Quality Care Recommendations

More information

Supplemental Table 1.1: Prostate cancer prognostic tools

Supplemental Table 1.1: Prostate cancer prognostic tools Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical

More information

Speaker bios Chordoma Community Conference at MD Anderson Cancer Center

Speaker bios Chordoma Community Conference at MD Anderson Cancer Center Speaker bios Chordoma Community Conference at MD Anderson Cancer Center Fredrick Castellano, MBA Fred Castellano is the Director of Managed Care Contracting for The University of Texas MD Anderson Cancer

More information

Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer

Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer Irish Experts Launch Global Report and Call for Increased Focus on Metastatic Breast Cancer Early detection does not help survival for metastatic breast cancer patients - average survival for women with

More information

The Changing Landscape of Palliative Care

The Changing Landscape of Palliative Care The Changing Landscape of Palliative Care KAHPC 17th Annual Conference August 2015 Brian Jones Joe Rotella Elizabeth Wessels Turner West Kay Williams Why Home-based Palliative Care? Turner West, MPH, MTS

More information

Day One Wednesday July 19, 2017

Day One Wednesday July 19, 2017 Day One Wednesday July 19, 2017 08.00 Registration & Coffee 09.00 Chair s Opening Remarks - Room: Huntington I/II Barbara Joyce-Shaikh, Associate Principal Scientist, Immunoncology, Merck Research Laboratories

More information

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine.

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine. Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine. 1 2 On April 30 the VU and VUMC transition was completed and we

More information

Connections. Academic and Community Cancer Research United (ACCRU) continues to expand our portfolio of cancer treatment

Connections. Academic and Community Cancer Research United (ACCRU) continues to expand our portfolio of cancer treatment Connections Vol. 7 No. 1 Spring 2017 Inside this issue Meeting news...2 Spring ACCRU Scientific Program Overview ACCRU to exhibit at ASCO 2017 Membership news...2 Top accruing members ACCRU welcomes new

More information

The Life Raft Group. Building Strategic Alliances

The Life Raft Group. Building Strategic Alliances The Life Raft Group Building Strategic Alliances The Life Raft Group Our Mission Is Survival Keeping GIST Patients Alive By Ensuring That no one dies because they cannot access treatment That no one dies

More information

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective

Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective 第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President

More information

Community Health Advisors- Utilizing Lay Navigators. Michael Bertram, PhD, MBA Associate Director for Administration

Community Health Advisors- Utilizing Lay Navigators. Michael Bertram, PhD, MBA Associate Director for Administration Community Health Advisors- Utilizing Lay Navigators Michael Bertram, PhD, MBA Associate Director for Administration Background & History Catchment Area Alabama 90% cancer patients Population 26.2% AA;

More information

November 12, The Honorable Nancy Pelosi Minority Leader United States House of Representatives

November 12, The Honorable Nancy Pelosi Minority Leader United States House of Representatives November 12, 2012 The Honorable John Boehner Speaker The Honorable Eric Cantor Majority Leader The Honorable Kevin McCarthy Majority Whip The Honorable Mitch McConnell Minority Leader The Honorable Jon

More information

CANCER FREE, SIX YEARS AND COUNTING!

CANCER FREE, SIX YEARS AND COUNTING! YOUR ANSWER TO CANCER. CANCER FREE, SIX YEARS AND COUNTING! Kim evens BREAST CANCER SURVIVOR nrocdoctors.com We re Here To Help. At NROC, patients always come first. As your partners in cancer care, we

More information

Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets

Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets Bibhas Chakraborty, PhD Centre for Quantitative Medicine, Duke-NUS March 29, 2015 Personalized or Precision Medicine

More information

2017FACTs. Discover. Care. Believe.

2017FACTs. Discover. Care. Believe. 2017FACTs Discover. Care. Believe. Who We Are Founded in Boston in 1947, Dana-Farber Cancer Institute is world-renowned for its leadership in adult and pediatric cancer treatment and research. A principal

More information

SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER

SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER Clinical Practice Guideline Update Introduction The original ASCO evidence-based clinical practice guidelines on use of sentinel node

More information

PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins.

PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins. Learn. Connect. Advocate. PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN 2016-18 Partners for a Hunger-Free Oregon Ending hunger before it begins. Dear Partners, This has been a year of celebration,

More information

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision LEADERSHIP PROFILE CURE Childhood Cancer Atlanta, Georgia CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision THE OPPORTUNITY This is a

More information

Strategic Directions

Strategic Directions Strategic Directions 2015-2019 Peter MacCallum Cancer Centre Strategic Directions 2015-2019 THE BEST IN CANCER CARE We are a cancer centre unsurpassed in the world, where humanity, caring service and relentless

More information

A Physician Leader s Role In Becoming A High Performing Health System

A Physician Leader s Role In Becoming A High Performing Health System A Physician Leader s Role In Becoming A High Performing Health System Byron C. Scott, MD, MBA Associate Chief Medical Officer, Truven Health Analytics Truven Health Analytics Inc. All Rights Reserved.

More information

Click to edit. Program in the Community

Click to edit. Program in the Community Master Developing a title Cardio-Oncology style Program in the Community Rick Chazal, MD, MACC Medical Director, Heart and Vascular Institute Lee Health, Fort Myers Florida Past President, ACC September

More information

Patrons. For further information please visit

Patrons. For further information please visit For further information please visit www.uea.ac.uk/boneandjoint Patrons Henry Cator OBE FRICS DL Ms Caroline Jarrold Mark Jeffries Richard Jewson JP MA Hon.DCL Viscountess Knollys OBE DL Norfolk Bone

More information

The Connecticut Cancer Partnership

The Connecticut Cancer Partnership The Connecticut Cancer Partnership Guest Expert: Lucinda Connecticut Cancer Partnership Program Director www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed Chu and

More information

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Thursday, May 4 Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Molecular Tumor Board - Case Presentation Lillian L. Siu, Patricio

More information

UNMC Nebraska Medicine Strategic Plan

UNMC Nebraska Medicine Strategic Plan UNMC Nebraska Medicine Strategic Plan 2017-2020 Overarching Goal 1: EDUCATION PROGRAMS: Enhance UNMC s and Nebraska Medicine s educational programs as the most learner-centered academic medical center

More information

Making social action part of life for all young people by 2020

Making social action part of life for all young people by 2020 Making social action part of life for all young people by 2020 2013-2016 / 2017-2020 The story so far Changing culture Youth Social Action makes sense We are failing to capitalise on the energy, talent

More information

The Heart Institute Tenth Anniversary Update. October 23, 2017

The Heart Institute Tenth Anniversary Update. October 23, 2017 The Heart Institute Tenth Anniversary Update October 23, 2017 Organizational Structure Medicine Surgery Imaging Anesthesiology Pediatrics Basic Biomedical Sciences BEFORE AFTER * Services provided by contract

More information

Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation

Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation Alliance Organizational Structure Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation May 10, 2017 NCI-NCTN National Cancer Institute (NCI) National Clinical

More information

Creating a Recovery- Oriented System of Care in Florida

Creating a Recovery- Oriented System of Care in Florida Creating a Recovery- Oriented System of Care in Florida A WINTER 2017 SUMMARY Achara Consulting Inc. 200 E. Randolph St., Suite 5100 Chicago, IL 60601 The Florida Department of Children and Families (DCF)

More information

PROGRESS UPDATE. The Prayers From Maria Foundation

PROGRESS UPDATE. The Prayers From Maria Foundation PROGRESS UPDATE The Prayers From Maria Foundation August 2016 EXECUTIVE SUMMARY Dana-Farber Cancer Institute is a global leader in discovery science and patient care for pediatric brain tumors, including

More information

Clinical Activity and Safety of Anti-PD-1 (BMS , MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer

Clinical Activity and Safety of Anti-PD-1 (BMS , MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer Clinical Activity and Safety of Anti-PD-1 (BMS-936558, MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer J.R. Brahmer, 1 L. Horn, 2 S.J. Antonia, 3 D. Spigel, 4 L. Gandhi, 5 L.V. Sequist,

More information

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan Planning Case Study Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan On the vanguard of thought. Reimagining The futurecancer of healthcare Care requires nothing less. Planning

More information

Comparative Effectiveness Research (CER) and Personalized Medicine: Policy, Science, and Business

Comparative Effectiveness Research (CER) and Personalized Medicine: Policy, Science, and Business Comparative Effectiveness Research (CER) and Personalized Medicine: How a comprehensive CER system can support personalized medicine Amy P. Abernethy, MD October 28, 2009 CER in Cancer Care? 2 Friends

More information

Caregiver Coalitions What It Takes To Build & Maintain An Active, Thriving Coalition

Caregiver Coalitions What It Takes To Build & Maintain An Active, Thriving Coalition Caregiver Coalitions What It Takes To Build & Maintain An Active, Thriving Coalition Sonnie Yudell, Program Manager Utah Division of Aging and Adult Services Past President, Utah Coalition for Caregiver

More information

YMCA Calgary. Strategic Plan

YMCA Calgary. Strategic Plan YMCA Calgary Strategic Plan YMCA Calgary Strategic Plan 2009 2013 In 2008, YMCA Calgary engaged its staff, Board of Directors and community partners to chart a course for the following five years. The

More information

Strategic Plan

Strategic Plan Strategic Plan 2013-2018 Strategic Plan 2013-2018 Contents The Challenges of an Aging Population.. Baycrest: fulfilling a legacy of commitment and accomplishment Looking Ahead: dedicated to serve our local

More information

CancerBase R E S E A R C H

CancerBase R E S E A R C H CancerBase R E S E A R C H CancerBase 1 WEB PRESENCE 4 ATOM HP 2 NCCN GUIDELINES 5 BIOINFORMATICS 3 CHOOSING DRUGS 6 MEDMIND Web Presence R E S E A R C H What is CancerBase trying to communicate? cancerbase.org

More information

BUILDING AN INFORMATION PLATFORM FOR CANCER RESEARCH & EVIDENCE-BASED HEALTHCARE

BUILDING AN INFORMATION PLATFORM FOR CANCER RESEARCH & EVIDENCE-BASED HEALTHCARE BUILDING AN INFORMATION PLATFORM FOR CANCER RESEARCH & EVIDENCE-BASED HEALTHCARE William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 17, 2013 MOFFITT

More information

Molecularly Targeted Therapies: Mechanisms of Resistance

Molecularly Targeted Therapies: Mechanisms of Resistance An AACR Special Conference on Molecularly Targeted Therapies: Mechanisms of Resistance May 9-12, 2012 Westin San Diego San Diego, CA Wednesday, May 9 7:00 p.m.-8:00 p.m. Opening Keynote Session BRAF and

More information

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX NOTE: Saturday, February 7 1:00 p.m.-3:00 p.m. Session A1: Cancer Genomics and Epigenomics Session Chairperson: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA Genomic heterogeneity in localized

More information

Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine

Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine Tze Leung Lai Dept. of Statistics, Biomedical Data Science, Computational & Mathematical Engineering;

More information

T E A M L E A D E R GUIDE

T E A M L E A D E R GUIDE TEAM LEADER GUIDE With your PASSION no one walks alone. The American Cancer Society has an important mission to free the world from the pain and suffering of breast cancer. Working with passionate, determined

More information